In the last years, major progress occurred in heart failure (HF) management. Quadruple
therapy is now mandatory for all the patients with HF with reduced ejection fraction. Whilst …

Pathogenic variants in genes that cause dilated cardiomyopathy (DCM) and arrhythmogenic
cardiomyopathy (ACM) convey high risks for the development of heart failure through …

Sažetak In the year 2021, the universal definition and classification of heart failure (HF) was
published that defines HF as a clinical syndrome with symptoms and/or signs caused by a …

Background Cardiac fibrosis is a hallmark of various end-stage cardiovascular diseases
(CVDs) and a potent contributor to adverse cardiovascular events. During the past decades …

Background: Tenascin-C (TN-C) plays a maladaptive role in left ventricular (LV) hypertrophy
following pressure overload. However, the role of TN-C in LV regression following …

Objectives Myocardial infarction (MI) commonly occurs in patients with coronary artery
disease and have high mortality. Current clinical strategies for MI still limited to reducing the …

Heart failure with preserved ejection fraction (HFpEF) is increasingly prevalent with a high
socioeconomic burden. Pharmacological heart rate lowering was recommended to improve …

The interactions and hemodynamic impact of transcatheter percutaneous mitral valve repair
(TMR) have not yet been investigated in patients undergoing left ventricular assist device …

Herzinsuffizienz ist ein klinisches Syndrom, welches durch funktionelle und strukturelle
Anomalien des Herzens verursacht wird, und ist weltweit die haufigste Todesursache. Die …

Our previous reports were well received by the readers. The full text of the reviews for 2014,
2015, 2016, 2017, 2018, 2019 1-6 were downloaded 807, 843, 638, 827, 841, and 199 …